Werewolf Therapeutics, Inc. - FORM S-1 - EX-23.1 - April 8, 2021

Attached files

file filename
S-1 - S-1 - Werewolf Therapeutics, Inc.d41037ds1.htm
EX-21.1 - EX-21.1 - Werewolf Therapeutics, Inc.d41037dex211.htm
EX-10.14 - EX-10.14 - Werewolf Therapeutics, Inc.d41037dex1014.htm
EX-10.13 - EX-10.13 - Werewolf Therapeutics, Inc.d41037dex1013.htm
EX-10.12 - EX-10.12 - Werewolf Therapeutics, Inc.d41037dex1012.htm
EX-10.11 - EX-10.11 - Werewolf Therapeutics, Inc.d41037dex1011.htm
EX-10.10 - EX-10.10 - Werewolf Therapeutics, Inc.d41037dex1010.htm
EX-10.9 - EX-10.9 - Werewolf Therapeutics, Inc.d41037dex109.htm
EX-10.3 - EX-10.3 - Werewolf Therapeutics, Inc.d41037dex103.htm
EX-10.2 - EX-10.2 - Werewolf Therapeutics, Inc.d41037dex102.htm
EX-10.1 - EX-10.1 - Werewolf Therapeutics, Inc.d41037dex101.htm
EX-4.2 - EX-4.2 - Werewolf Therapeutics, Inc.d41037dex42.htm
EX-3.4 - EX-3.4 - Werewolf Therapeutics, Inc.d41037dex34.htm
EX-3.3 - EX-3.3 - Werewolf Therapeutics, Inc.d41037dex33.htm
EX-3.2 - EX-3.2 - Werewolf Therapeutics, Inc.d41037dex32.htm
EX-3.1 - EX-3.1 - Werewolf Therapeutics, Inc.d41037dex31.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement on Form S-1 of our report dated February 26, 2021, relating to the financial statements of Werewolf Therapeutics, Inc. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Boston, Massachusetts

April 8, 2021